ArticleCancer medicine2019

Real-world outcomes of various regimens of recombinant human endostatin combined with chemotherapy in non-driver gene mutation advanced non-small cell lung cancer.

Zhongtai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.